Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
Molecular Imaging
|
January 20, 2018
Commentary to <sup>18</sup>F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots-Are We Getting There?
Andrew W Stephens, Norman Koglin, Ludger M Dinkelborg
EJNMMI Radiopharmacy and Chemistry
|
March 23, 2018
New protein deposition tracers in the pipeline
Aleksandar Jovalekic, Norman Koglin, Andre Mueller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 28, 2017
Validation of Noninvasive Tracer Kinetic Analysis of <sup>18</sup>F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol
Santiago Bullich, Henryk Barthel, Norman Koglin, et al.
Radiology
|
January 20, 2016
Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers
Camila Mosci, Meena Kumar, Kamilla Smolarz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 2, 2025
In Vivo Head-to-Head Comparison of [<sup>18</sup>F]GTP1 with [<sup>18</sup>F]MK-6240 and [<sup>18</sup>F]PI-2620 in Alzheimer Disease
Emily Olafson, Matteo Tonietto, Gregory Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2011
Specific PET imaging of xC- transporter activity using a ¹⁸F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism
Norman Koglin, Andre Mueller, Mathias Berndt, et al.
Nucleic Acids Research
|
October 29, 2004
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
Kathrin S Schmidt, Sandra Borkowski, Jens Kurreck, et al.
Alzheimer'S Research & Therapy
|
March 10, 2026
In-vitro interaction studies between the amyloid PET tracer florbetaben and the amyloid-beta targeting antibodies lecanemab and donanemab on AD brain samples reveal no interferences
Andre Mueller, Aleksandar Jovalekic, Marianne Chapleau, et al.
European Radiology
|
July 21, 2022
Value of <sup>68</sup>Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [<sup>18</sup>F]fluoromethylcholine PET-CT and multiparametric MRI-a phase I/II study
Mohsen Beheshti, Pekka Taimen, Jukka Kemppainen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2025
A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
Clément Morgat, Heying Duan, Simone Dalm, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
Molecular Imaging
|
January 20, 2018
Commentary to <sup>18</sup>F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots-Are We Getting There?
Andrew W Stephens, Norman Koglin, Ludger M Dinkelborg
EJNMMI Radiopharmacy and Chemistry
|
March 23, 2018
New protein deposition tracers in the pipeline
Aleksandar Jovalekic, Norman Koglin, Andre Mueller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 28, 2017
Validation of Noninvasive Tracer Kinetic Analysis of <sup>18</sup>F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol
Santiago Bullich, Henryk Barthel, Norman Koglin, et al.
Radiology
|
January 20, 2016
Characterization of Physiologic (18)F FSPG Uptake in Healthy Volunteers
Camila Mosci, Meena Kumar, Kamilla Smolarz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 2, 2025
In Vivo Head-to-Head Comparison of [<sup>18</sup>F]GTP1 with [<sup>18</sup>F]MK-6240 and [<sup>18</sup>F]PI-2620 in Alzheimer Disease
Emily Olafson, Matteo Tonietto, Gregory Klein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 14, 2011
Specific PET imaging of xC- transporter activity using a ¹⁸F-labeled glutamate derivative reveals a dominant pathway in tumor metabolism
Norman Koglin, Andre Mueller, Mathias Berndt, et al.
Nucleic Acids Research
|
October 29, 2004
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
Kathrin S Schmidt, Sandra Borkowski, Jens Kurreck, et al.
Alzheimer'S Research & Therapy
|
March 10, 2026
In-vitro interaction studies between the amyloid PET tracer florbetaben and the amyloid-beta targeting antibodies lecanemab and donanemab on AD brain samples reveal no interferences
Andre Mueller, Aleksandar Jovalekic, Marianne Chapleau, et al.
European Radiology
|
July 21, 2022
Value of <sup>68</sup>Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [<sup>18</sup>F]fluoromethylcholine PET-CT and multiparametric MRI-a phase I/II study
Mohsen Beheshti, Pekka Taimen, Jukka Kemppainen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2025
A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
Clément Morgat, Heying Duan, Simone Dalm, et al.
Page
of 8